FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

MYCOLOG-II-1

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 27 USDMF, 11 CEP/COS, 5 JDMF, 9 EU WC, 20 KDMF, 29 NDC API, 1 VMF, 36 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

73 Drugs in Development

73 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 232 FDA Orange Book, 83 Europe, 17 Canada, 2 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 10MG/ML, SPRAY;TOPICAL - 0.147MG/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 40MG/ML, INJECTABLE;INJECTION - 80MG/ML, SPRAY, METERED;NASAL - 0.055MG/SPRAY, FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL, CREAM;TOPICAL - 0.025%, CREAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.5%, OINTMENT;TOPICAL - 0.025%, OINTMENT;TOPICAL - 0.1%, OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 9 SPI Pharma, 1 Pharm-RX Chemical, 3 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 12 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 22 BASF, 3 CD Formulation, 1 Clariant, 2 DFE Pharma, 2 Esteem Industries, 6 Finar, 12 Gangwal Chemicals, 4 Gloria Interchem, 1 Ideal Cures, 1 JJ Chemicals, 2 Kerry, 2 Keval Exports, 1 Kima Chemical, 3 Lonza Capsugel, 11 Microlex e.U, 1 Nanjing Bold Chemical, 1 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Prachin Chemical, 1 Qualicaps, 19 Roquette, 12 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Silverline Chemicals, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

41 Topical, 39 Solubilizers, 37 Parenteral, 36 Thickeners and Stabilizers, 24 Fillers, Diluents & Binders, 19 Film Formers & Plasticizers, 18 Emulsifying Agents, 16 Surfactant & Foaming Agents, 12 Direct Compression, 12 Coating Systems & Additives, 11 Co-Processed Excipients, 10 Controlled & Modified Release, 9 Taste Masking, 8 Granulation, 8 Empty Capsules, 7 Chewable & Orodispersible Aids, 6 Rheology Modifiers, 5 Disintegrants & Superdisintegrants, 4 Lubricants & Glidants, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

111 News #PharmaBuzz

111 News #PharmaBuzz

GLOBAL SALES INFORMATION

53 US Medicaid Prescriptions, 32 Regulatory FDF Prices

MARKET PLACE

30 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 JP

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
27/02/2026	Axplora	Germany	Farmabios S. p. A.	305MF10085	Triamcinolone acetonide	2023-07-19	2025-01-09	Via Pavia, 1-27027 Gropello Cairoli, Pavia, Italy
27/02/2026	Curia	U.S.A	Curia Spain S. A. U.	221MF10001	Japanese Pharmacopoeia Triamcinolone Acetonide Sterile	2009-01-13	2025-08-21	Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

MYCOLOG-II-1

MYCOLOG-II-1

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers

27 USDMF

11 CEP/COS

5 JDMF

9 EU WC

20 KDMF

29 NDC API

1 VMF

36 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

73 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

232 FDA Orange Book

83 Europe

17 Canada

2 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 10MG/ML

SPRAY;TOPICAL - 0.147MG/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 40MG/ML

INJECTABLE;INJECTION - 80MG/ML

SPRAY, METERED;NASAL - 0.055MG/SPRAY

FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR - 32MG/VIAL

CREAM;TOPICAL - 0.025%

CREAM;TOPICAL - 0.1%

CREAM;TOPICAL - 0.5%

OINTMENT;TOPICAL - 0.025%

OINTMENT;TOPICAL - 0.1%

OINTMENT;TOPICAL - 0.5%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

9 SPI Pharma

1 Pharm-RX Chemical

3 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

12 Kirsch Pharma

4 ACG Worldwide

15 Actylis

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

22 BASF

3 CD Formulation

1 Clariant

2 DFE Pharma

2 Esteem Industries

6 Finar

12 Gangwal Chemicals

4 Gloria Interchem

1 Ideal Cures

1 JJ Chemicals

2 Kerry

2 Keval Exports

1 Kima Chemical

3 Lonza Capsugel

11 Microlex e.U

1 Nanjing Bold Chemical

1 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Prachin Chemical

1 Qualicaps

19 Roquette

12 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

1 Silverline Chemicals

CREAM;TOPICAL - 0.025% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY;TOPICAL - 0.147MG/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons